MoneyWorks4Me

Biocon informs about company statement

23 Jul 2025 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Biologics Launches Nepexto®, a Biosimilar to Enbrel® (Etanercept), in Australia’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..